<DOC>
	<DOCNO>NCT02567149</DOCNO>
	<brief_summary>The primary objective determine whether intralesional cidofovir effective bringing total near-total resolution wart already proven recalcitrant standard therapy . The secondary objective determine tolerability new mode administration cidofovir pediatric population</brief_summary>
	<brief_title>Intralesional Cidofovir Treatment Recalcitrant Warts Pediatric Immune-suppressed Population .</brief_title>
	<detailed_description>This study include pediatric patient history either primary iatrogenic immune-suppression seek treatment wart already proven recalcitrant standard therapy . The first cohort include 4 patient age 12 17 . After test indicate treatment safety , second cohort recruit include patient age 8 17 .</detailed_description>
	<mesh_term>Warts</mesh_term>
	<mesh_term>Cidofovir</mesh_term>
	<criteria>1 . The first cohort include total 4 patient age 12 17 . After test indicate treatment safety , second cohort recruit include patient age 8 17.Patient immunesuppressed status one following : 1 . Primary immunodeficiency , may include limited following : 1 . Chronic Granulomatous Disease ( CGD ) 2 . Common Variable Immunodeficiency ( CVID ) 3 . DiGeorge Syndrome ( DGS ) 4 . Selective IgA Deficiency 5 . Severe Combined Immunodeficiency ( SCID ) 6 . XLinked Agammaglobulinemia ( XLA ) 2 . Pharmacologic immunesuppressed status medication include limited : 1. prednisone 2. cyclosporine 3. azathioprine 4. tacrolimus/ FK506 5. mycophenolate mofetil 6. sirolimus 2 . Patient history clinicallysignificant warts either refractory standard therapy standard therapy contraindicate unreasonable 3 . Patient total wart burden least 1cm 4 . Patients must try fail least 2 conventional treatment cutaneous wart , include limited : cryotherapy topical salicylic acid imiquimod topical 5FU pulsed dye laser therapy sinecatechins tretinoin topical retinoid intralesional candida injection bleomycin electrocautery topical cidofovir cream gel There one month washout period treatment modality , exception intralesional candida , 3 month . 5 . Patient desire ongoing treatment wart 6 . Patient and/or parent/guardian consent participate study 1 . Treatment area either ulcerated , secondarily infect , significantly inflame 2 . Treatment area face groin area 3 . Patient pregnant , attempt become pregnant , lactate 4 . Patient report active kidney disease , chart review reveals recent serum creatinine â‰¥1.5mg/dL history renal disease/insufficiency history diabetes 5 . Patient currently receive nephrotoxic medication 6 . Patient history hypersensitivity cidofovir 7 . Patient severely ill and/or hospitalize 8 . Patient receive chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Wart</keyword>
</DOC>